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In  the  preceding  paper  of  this  series,  we  reported  that  CBA/HN  mice 
(C mice), a  genetically distinct subline of CBA  mice,  produce  an  extremely 
low, if any, IgM antibody response to Type III pneumococcal polysaccharide 
(SSS-III) ~ and  to other polysaccharide antigens  (1).  Evidence was  also pre- 
sented  to  indicate  that  such  mice  lack  an  X-linked  gene  that  governs  re- 
sponsiveness to SSS-III in a decisive manner (1). Since the X  chromosome of 
man has been reported to carry genes that influence IgM immunoglobulin levels 
(2--4),  and  since  several  immune  deficiency diseases  appear  to  be X-linked 
(5-8), this study was undertaken to determine whether the failure of C mice 
to  respond  to  SSS-III  can  be attributed largely to  an  impairment  in  their 
ability to synthesize IgM immunoglobulin. Serum IgM levels were studied in 
detail because mice immunized with SSS-III produce antibodies mostly of this 
immunoglobulin class. The results obtained show that  C  mice are unable to 
make a normal IgM antibody response to polysaccharide antigens, despite the 
fact that they possess the capacity to synthesize normal amounts of IgM im- 
munoglobulin if antigen specific stimulation is bypassed. 
Materials and Methods 
Antigens and Immunization Procedures.--The immunological properties of the Type III 
pneumococcal  polysaccharide (SSS-III) used have been described (9-12). Mice were given a 
single intraperitoneal injection of an optimally immunogenic  dose (0.5/zg) of SSS-III in 0.5 
ml saline. The magnitude of the antibody response produced was assessed 5 days later. 
Escherichia coli 0127 (lot 478203), Salmonella typkosa 0901 (lot 578448), Salmonella typki- 
raurium (lot 579433), and Serratia marcescens (lot 577446) lipopolysaccharides  (LPS) were 
1  Abbreviations used in this paper: B mice, BALB/cAnN; C mice, CBA/HN mice; LPS, 
lipopolysaccharides; PFC,  plaque-forming cells; SSS-III,  Type III  pnuemococcal poly- 
saccharide. 
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purchased from Difco Laboratories, Detroit, Mich. Mice were given either one or a series of 
six intraperitoneal injections (two injections a week for 3 wk) of 10 #g of LPS in 0.5 ml saline. 
Serum samples were collected 5 days after the last injection of LPS, and assayed for their 
hemolytic (IgM) antibody content. 
Immunological Methods.--The procedures used for the detection of serum hemolytic (IgM) 
antibody and plaque-forming cells (PFC) specific for SSS-III or LPS has been described (1). 
Serum antibody titers were expressed as 1/log2 of the highest dilution of serum giving com- 
plete hemolysis of a standard suspension of antigen-coated sheep erythrocytes (1); values for 
the PFC response were expressed as PFC/spleen or PFC/10  6 nucleated spleen cells (1). 
Serum IgM immunoglobulin levels (mg IgM/ml serum) were determined by a modification 
of the technique of single radial diffusion (13, 14) as described by Biozzi et al. (15). The serum 
samples used for this purpose were the same as those employed for the detection of hemolytic 
(IgM) antibody in these or in previous studies (1), and were obtained 5 days after immuniza- 
tion with SSS-III or LPS. The results of preliminary studies affirmed that the IgM immuno- 
globulin levels of mice immunized with SSS-III were no greater than those of nonimmunized 
mice (unpublished observations). 
Animals.--BALB/cAnN,  CBA/HN  mice,  and  progeny  derived  from  crosses  involving 
these two strains of mice were obtained from the Rodent and Rabbit Production Section of 
the National Institutes of Health (NIH), Bethesda, Md. CBA/CaJ mice were purchased from 
The Jackson Laboratories, Bar Harbor, Maine. All mice were 8-12 wk of age at the time of 
use. 
Genetic No~tion.--The  notation of Gill et al.  (16)  was used to designate parental strains 
of mice, as well as F1, F2, and backcross generations. BALB/cAnN and CBA/HN mice were 
referred to as B  mice and C  mice, respectively. The first symbol used to describe a  hybrid 
identifies the maternal member of a  cross,  e.g.,  CB mice are F1 mice derived from a  cross 
between female C mice and male B mice. For progeny derived from backcrosses, the symbol 
preceding the slash mark  denotes the maternal member of the cross,  e.g.,  CB/B mice are 
progeny derived from a  backcross between female CB  (F1 mice) and male B  mice. F2 mice 
were referred to as either CB//CB or BC/BC mice. 
The symbols X + and X- were used to indicate the presence or absence of an X-linked gene 
that governs, in a  decisive manner, the ability of mice to give an antibody response to SSS- 
III  (1).  Since this gene appears to be present in B  (X+X  +, X+Y) but not C  (X-X-, X-Y) 
mice (1), progeny derived from all crosses considered were classified accordingly with respect 
to their expected genotype. 
Classification  of Mice  with  Respect  to  Their Ability  to  Respond  to SSS-III.--Miee  were 
classified as low, intermediate, or high responders according to the magnitude of the PFC 
and  serum antibody response produced  5  days after immunization with an  optimally im- 
munogenic dose (0.5 #g) of SSS-III; the criteria used have been described in detail elsewhere 
(1).  Briefly,  C  mice  regularly give an  extremely  low  mean PFC  response  (<1,000  PFC/ 
spleen,  < 12 PFC/106 spleen cells) and no serum antibody can be detected  (1/log2  <1); all 
mice giving a  C  type of antibody response were classified as low responders. In contrast, B 
mice produce the highest mean PFC and serum antibody response observed (> 13,000 PFC/ 
spleen,  >70 PFC/106 spleen cells,  and  1/log2 >7.0); all mice giving a  B  type of antibody 
response were considered to be high responders. Mice giving an antibody response greater than 
that of C mice, but less than that of B mice, were classified as intermediate responders. The 
results of previous studies showed that for progeny derived from crosses between C  and B 
mice, all X+X  + and X+Y mice were high responders, all X+X  -  mice were intermediateresponders, 
and all X-X-  and X-Y mice were low responders (1). 
Statistics.--Student's  t test (17) was used to evaluate the significance of the differences ob- 
served. Differences were considered to be significant when probability (P) values <0.05 were 
obtained. AMSBAUGH  ET  AL.  1501 
RESULTS 
Antibody  Responses Produced by  Mice  Derived from  Reciprocal Crosses.- 
The magnitude of the PFC and serum antibody response to an optimally im- 
munogenic dose (0.5 #g) of SSS-III was determined for BC and BC/BC mice, 
as well  as for mice derived from backcrosses between BC  mice and  B  or  C 
mice; such mice constitute progeny of crosses that are  the  reciprocals of those 
considered earlier (1). With respect to the incidence of low responders obtained, 
the  data  of Table  I  were not  only in  accord with,  but  also  confirmed, our 
original hypothesis (1), namely, that a major component involved in the anti- 
body response  to  SSS-III  is  X-linked  and  appears  to  be present  on  the  X 
chromosome of high  responding B  mice  (X+X  +  or X+Y  mice),  but not  low 
responding C mice (X-X- or X-Y). Furthermore, these data also suggest that 
TABLE  I 
Magnitude of the PFC and Serum Antibody Response  Produced by Male and Female 
Progeny from  Various Crosses 
Mice 
BC 
BC/BC 
B/BC 
B C/B 
C/BC 
BC/C 
1/log2 serum 
PFC/spleen  PFC/10  s  spleen cells  antibody titer 
Hypothetical 
genotype 
Mean 
loglo 4- S~:~ 
X+X -  3.62  4-  6.04 
(4179) 
X+Y  3.73  4-  0.03 
(5371) 
(X+X +, X+X-:  3.7~, -4-  0, 04 
(6080) 
X+Y  3.82  4-  0.06 
(6645) 
X-Y  NC§ 
X+X  +  3.74  -4-- 0.07 
(5530) 
X+Y  3.82  4-  0.06 
(6596) 
(X+X +, X+X-I  3.82  -4-  0.05 
(6592) 
X+Y  4.01  4-  0.04 
(10,136) 
X-Y  NC 
X+X  -  3.37  4-  0.15 
(2346) 
X-Y  NC 
X-X-  NC 
X+X  -  3.37  4-  0.11 
(2338) 
X+Y  3.39 4-  0.09 
(2431) 
X-Y  NC 
Mean i  S~ 
5.72 =h  0.14 
6.36 -4-  0.14 
6.40  -4-  0.15 
6.14  -4-  0.19 
NC 
6.61  4-  0.16 
6.16 4-  0.22 
5.84  4-  0.19 
5.40 4-  0.47 
NC 
5.20  ±  0.26 
NC 
NC 
4.50  4-  0.27 
5.50 "4-  0.22 
NC 
* No. of mice giving  a stated response on the basis of genotype/total no. of mice examined. 
~; Geometric means are shown in parentheses. 
§ Not calculable, since no PFC or serum antibody could be detected  in all but a  few of the mice examined. 
11 No serum antibody detected in any of the mice examined. 
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additional factors, presumably autosomal genes, may act in a complex manner 
to influence the magnitude of the antibody response produced by mice having 
the  same h)q3othetical  genotype with  respect  to  the  X-linked  gene.  For  ex- 
ample, among X+Y mice,  the  response produced  by BC/B  mice was similar 
to that of high responding B mice (1); however, BC, BC/BC, B/BC, and BC/C 
mice gave low to intermediate responses. The basis for such quantitative dif- 
ferences will be considered later in this paper in relation to the results obtained 
in other studies. 
Responses  Produced  by  Genotypieally  Identical  Reciprocal  F1  Mice.--Since 
female BC and  CB mice possess identical  genotypes,  these mice should have 
responded similarly to SSS-III; this was not the case. Instead, the magnitude 
of both  the  PFC  and  serum  antibody  responses  of  CB  mice  (Table  II) was 
significantly greater (about  two-fold)  than  that produced  by BC mice (P  < 
0.001 for all three immunological parameters considered). 
Serum  IgM  Levels  of Mice  Giving  a  High,  Intermediate,  or  Low  Antibody 
Response to SSS-III.--Serum  IgM levels were determined for B  and C  mice, 
as well as for progeny derived from all of the crosses and backcrosses considered 
in this and  the previous work  (1).  Almost all  (>80%)  of the serum samples 
collected during the course of these investigations were used/or such analyses; 
consequently,  the results obtained provide representative values for the mag- 
nitude,  range and distribution of IgM levels for each group of mice examined. 
All samples used were identified with respect to the cross, or parental  strains 
of mice, from which they were derived and were classified as to whether they 
were  obtained  from high,  intermediate  or low  responders  to  SSS-III. Histo- 
grams, such  as  those illustrated  in  Fig.  1,  were constructed  for all groups of 
serum  samples assayed in  order  to  determine  whether  one  or  more  discrete 
distributions of IgM levels were present within each group of mice. 
During the entire course of this study, only two types or categories of IgM 
levels were encountered;  both are depicted  in  Fig.  1 and were referred to as 
low  IgM  levels  (0.10-0.35  mg IgM/ml)  and  high  IgM  levels  (0.40-1.00  nag 
IgM/ml). Since almost all  (about 95 %) of the serum samples examined could 
TABLE  II 
Differences Between Female BC  and  CB  Mice in their Ability  to Respond to an Optimally 
Immunogenic Dose (0.5 #g) of SSS-111 
No. of  Hypothetical  Mice  PFC/spleen  PFC/10s  1/log~ serum 
mice  genotype  spleen cells  antibody titer 
Mean loglo 4- S~  Mean ±  S~ 
67  X+X  -  BC  3.62  -4- 0.04  1.43  -4- 0.03  5.72  ±  0.14 
(4,179)*  (27) 
63  X+X  -  CB  3.90  -4- 0.03  1.62  ±  0.03  6.75  ±  0.27 
(7,940)  (42) 
* Geometric means are shown in parentheses. AMSBAUGH ET  AL.  1503 
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FIG. 1.  IgM levels of male and female F2 mice. Each point shown indicates the IgM level 
(mg/ml) of a single mouse. O, low antibody response to SSS-III; O, high antibody response 
to SSS-III; ~, intermediate response to SSS-III. 
be assigned, with no difficulty, to one of these two categories or distributions, 
histograms for the remaining groups of serum samples assayed are not shown; 
rather,  only mean values for one or each of the two categories of IgM levels 
present  are listed  in  Tables III and  IV.  The  results  obtained  show  that  all 
low responders to SSS-III had low IgM levels. However, even though the anti- 
body response to SSS-III is predominantly an IgM antibody response (9,  10, 
18),  both high and intermediate responders had high IgM levels of the same 
magnitude. Whereas the IgM levels of man have been reported to be influenced 
directly  by an X-linked  gene  dose  effect  (2-4),  the  IgM  levels of  the  mice 
examined  in  the  present  work  appeared  to  be  transmitted  as  an  X-linked 
dominant  trait.  For example, X+X  + and X+X  -  mice differed with respect to 
gene  dose  for  the  X-linked  component  and  responsiveness  to  SSS-III; yet, 
the IgM levels of these mice were almost identical. 
Eject of Treatment with LPS on the Magnitude of the IgM Levels of B  and 
C mice.--B and C were given one or more injections of 10/zg of LPS derived 
from different bacterial species; such treatment has been shown to result in a 
substantial  increase in  IgM level  (19).  5  days after the last injection,  serum 
samples were collected and  assayed for the presence of antibody specific for 
LPS, as well as for their IgM content. 
Treatment with LPS resulted  in about a  four- to ninefold  increase  in  the 
IgM levels of C mice (Table V) ; the resultant values obtained (0.60-1.24 mg/ml) 
were at least as great,  or greater, than those of B  mice no  t  given LPS  (0.50 
mg/ml, Tables III and IV). More important, in spite of the increased amounts 1504  GENETIC  CONTROL  OF  ANTIBODY  RESPONSE  TO  SSS-III.  II. 
TABLE III 
Serum IgM Immunoglobulin Levels of Female Mice Derived  from Various Crosses 
No. 
of 
mice 
21 
23 
33 
30 
25 
42 
8 
46 
15 
40 
17 
29 
10 
10 
44 
74 
26 
Hypothetical 
genotype 
X+X + 
X+X - 
~t 
X-X- 
gg 
g~ 
gg 
(X+X  + X+X  -) 
Type of response 
to SSS-III 
High 
Intermediate* 
Intermediate 
Low 
(High -'k inter- 
mediate) :~ 
Mice 
B 
B/BC 
B/CB 
CB/CB 
cu/c 
BC 
BC/C 
CS 
C/BC 
CB/CB 
CB/C 
C/CB 
BC/C 
C 
BC/B 
BC/BC 
CB/B 
IgM immunoglobulin  level 
Geometric  Logl0 mean  i  S~ 
mean 
0.500 
0.568 
0.642 
0.640 
0. 740 
0.593 
0.602 
0.662 
0.488 
0.195 
0.113 
0.122 
0.053 
0.140 
0.451 
0.584 
0.586 
mg/ml serum 
[--0.301 
-0.246 
±  0. 030 
±  0.028 
--0.192  ±  0.019 
--0.194 -4- 0.032 
--0.131  ±  0.018 
--0.227  ±  0.017 
--0.220 ±  0.058 
--0.179  ±  0.013 
--0.312  ±  0.034 
--O.709  ±  0.031 
--0.948  ±  0.046 
--0.915  ±  0.026 
--1.276 ±  0.125 
--0.854 ±  0.030 
--0.345 ±  0.017 
--0.234 ±  0.015 
--0.232 ±  0.019 
* These mice gave an intermediate  PFC response and their  serum antibody titers  were 
lower than expected on the basis of their  hypothetical  genotype; consequently, they were 
classified as intermediate  responders. 
:~ Both high and intermediate  responders were present;  these could not be distinguished 
from each other. 
of  IgM  immunoglobulin produced,  no  serum  antibody,  specific  for  E.  col± 
LPS, could be detected (Table VI). Lesser increases (two- to threefold) in IgM 
immunoglobulin were  noted for  B  mice given LPS  (Table V)  and although 
antibody specific for E. col± LPS could be detected (Table VI), there appeared 
to  be no directed relationship between IgM levels and the amount of serum 
antibody found. Multiple injections of E. col± LPS resulted in still higher IgM 
levels (1.50 mg/ml); yet, the serum antibody titers obtained were lower than 
those of mice given only one injection of LPS. 
Treatment with S. typhosa, S. typhimurium,  and S. marcescens LPS likewise 
increased the IgM levels of both B  and C mice (Table V); but neither B or C 
mice produced a  measurable serum antibody response to these antigens (data 
not shown). It has not been established whether these preparations of LPS were AMSBAUGH  ET  AL.  1505 
TABLE IV 
Serum IgM Immunoglobulin Levels  of Male Mice Derived from  Various Crosses 
IgM immunoglobulin level 
No.  Hypo-  Type of response 
of  thetical  Mice 
mice  genotype  to SSS-III  Geometric  Log10  mean :l: S£ 
mean 
mg/ml serum 
37  X+Y  High  B  0.490  --0.310  4-  0.020 
4  "  "  CB/B  0.647  --0.189  +  0.023 
15  "  "  BC/B  0.529  --0.276  4-  0.040 
36  "  "  B/CB  0.597  --0.224  4-  0.016 
34  "  "  CB/CB  0.670  --0.174  4-  0.020 
26  "  "  CB/C  0.603  --0,219  4-  0.022 
74  "  Intermediate*  BC  0.616  --0.210  4-  0.011 
19  ....  B/BC  0.525  --0.279  4-  0.033 
32  ....  BC/BC  0.635  --0.197  4-  0.019 
9  ....  BC/C  0.515  --0.288  4-  0.043 
7  X-Y  Low  CB/B  0.218  --0.662  -4-  0.058 
12  "  "  BC/B  0.053  --1.276  -4-  0.066 
37  "  "  BC/BC  0.171  --0.766  4-  0.032 
18  "  "  C/BC  0.049  --1.306  4-  0.075 
20  "  "  CB/CB  0.189  --0.723  4-  0.029 
26  "  "  CB/C  0.099  --1.003  4-  0.030 
35  "  "  C/CB  0.101  --0.995  4-  0.030 
9  "  "  BC/C  0.057  --1.247  4-  0.174 
20  "  "  C  0.181  --0.743  4-  0.031 
91  "  "  CB  0.142  --0.847  4-  0.014 
* These mice gave an intermediate PFC response and  their serum antibody titers were 
lower than expected  on  the basis of their hypothetical genotype;  consequently,  they were 
classified as  intermediate  responders. 
weakly  immunogenic for  both  of  the  strains  of mice  used,  or  whether  they 
failed to function properly in the procedure used for the detection of antibody 
specific for LPS. 
IgM  Levels  and  SSS-III-Specific  Antibody  Response  of  CBA/CaJ  Mice.-- 
IgM levels, in addition to PFC and serum antibody responses to 0.5 pg SSS-III, 
were determined for CBA/CaJ mice; the results of homograft and mixed lym- 
phocyte culture studies affirmed that these mice are histocompatible with the 
low responding C  mice used in this work (to be published). The data of Table 
VII show that,  although the IgM levels of CBA/CaJ mice were virtually the 
same as those of high responding B  mice (Tables II and III), CBA/CaJ mice 
gave  a  low  to  intermediate  PFC  and  serum  antibody  response  to  SSS-III. 
These findings,  in  addition  to  those  of Tables  II and  III, indicate that  mice 
having high IgM levels do not necessarily give a  high IgM antibody response 
to SSS-III. 1506  GENETIC  CONTROL  OF  ANTIBODY  RESPONSE  TO  SSS-IIL  II. 
TABLE  V 
Effect  of Treatment  with Different  Types  of LPS  Preparations on the  Serum  IgM 
Immunoglobulin Levels  of B  and C Mice 
Treatment  IgM immunoglobulin  level 
No.  LPS  Dose  injections  B mice  C mice 
Izg/mouse  mg/ml serum 
E. coli  10  1  1.11"  0.60 
(0.043  4-  0.033)~  (--0.219  +  0.048) 
10  6§  1.50  0.936 
(0.176  4.  0.019)  (--0.029  ±  0.088) 
S. typhosa  10  1  1.08  0.940 
(0.034  4.  0.023)  (--0.027  -4- 0.024) 
S. typhimurium  10  1  1.39  1.24 
(0.142  q-  0.033)  (0.093  q-  0.041) 
S. marcescens  10  1  1.63  1.11 
(0.213  4.  0.048)  (0.046  4-  0.031) 
* Geometric mean. 
:~ Log10 -4- S~ for 3-7 mice; all determinations  were made on serum samples collected 5 
days after the last injection of LPS. 
§ Two injections a week for 3 wk. 
DISCUSSION 
Cooperation between  "helper"  T  cells and bone marrow-derived precursors 
of antibody-forming cells  (B  cells)  has  not  been found to  be  required  for an 
antibody response to SSS-III, a  linear polymer composed of identical  epitopes 
(20-25).  Consequently,  the antibody response  to this antigen is  considered to 
be largely a  B<ell  response in which the antibody produced is predominantly 
of the  IgM  class  (22,  24).  Furthermore,  the  avidity of antibody  specific for 
SSS-III remains  essentially consistent over a  10,000-fold range of immunizing 
doses and after  reimmunization  with low or high doses of antigen,  indicating 
the lack of an antigen-mediated  cell selection process (26).  These findings are 
consistent with the view that the antibody response to SSS-III is the result of 
the direct stimulation  by antigen  of a  highly restricted population or clone of 
B  cells. 
The results of these and of previous studies (1, Table I) show that CBA/HN 
mice (C mice) lack an X-linked gene that plays a  decisive role in determining 
responsiveness,  not only to SSS-III, but also to other polysaccharide antigens 
that elicit primarily an IgM antibody response.  Since several immunoglobulin 
deficiency diseases of man have been reported to be X-linked (5-8), one objec- 
tive of this study was to determine whether the failure of C mice to respond to 
polysaccharide antigens was the result of a defect in their capacity to synthesize 
IgM immunoglobulin. The results obtained (Tables III and IV) showed that C 
mice, as well as all other mice lacking the X-linked gene, i.e. all X-X-  or X-Y AMSBAUGtt  F,T  AL.  1507 
TABLE  VI 
Serum Hemolytic (IgM)  Antibody Titers of B and C Mice Immunized with E. coli LPS 
Immunization procedure  Serum antibody titer 
Dose  No. injections  B mice  C mice 
Izg 
10  1  6.20  4- 0.58*  None detected 
10  6  3.29  4- 0.68  None detected 
* 1/log2 4- S~ for 5-8 mice; all determinations were made 5 days after the last injection 
of LPS. 
TABLE  VII 
Serum IgM Immunoglobulin Levels, PFC, and Serum Antibody Reponses of CBA/CaJ Mice 
Immunized with 0.5 #g  of SSS-III 
Sex 
Male 
Female 
NO. 
nice 
8 
15 
IgM levels 
mglml serum 
--0.25  ±  0.04* 
(0.56) 
--0.26  -4- 0.02 
(0.55) 
Mean antibody response to SSS-III 
PFC/spleen 
3.54  4-  0.128" 
(3,491) 
3.344  4-  0.089 
(2,210) 
PFC/10  s  spleen cells 
1.387  4-  0.138" 
(24) 
1.132  4-  0.081 
(14) 
Serum antibody 
5.58  4-  0.025 
6.00  4-  0.00 
* Log10 4- S~; geometric means in parentheses. 
:~ 1/log2  -4- S~. 
mice, had IgM levels much lower than those of mice possessing this gene. Such 
low levels could reflect either an inability to respond to polysaccharide antigens 
encountered  in  the  environment,  or an  inability  to make IgM  antibodies  in 
response  to most antigens.  However,  the  fact that  treatment  with  bacterial 
lipopolysaccharides (LPS)  resulted in a  substantial increase in the IgM levels 
of C mice (Table V) indicates that the biosynthetic machinery required for the 
production  of IgM immunoglobulin is intact,  and  that  the X-linked  genetic 
defect observed is most likely related to the mechanism involved in triggering 
lymphocytes to differentiate following antigenic  stimulation.  In this  context, 
it should be noted that LPS is considered to be a B-cell mitogen (27, 28) and may 
stimulate  lymphocytes  to  produce  IgM  immunoglobulin  by a  process  inde- 
pendent  from that  involving antigen-specific receptors; the fact that  C  mice 
produce large amounts of IgM immunoglobulin, but no specific antibody follow- 
ing treatment with LPS (Table VI), provides support for such a view. 
All of the mice examined in this and the previous work (1) could be classified 
as being low, intermediate, or high responders to SSS-III; the magnitude of the 
antibody  response  produced  after  immunization  with  SSS-III  was  related 
directly to gene-dose for the X-linked component (1,  Table I). However, no 
such  relationship  was  observed with  respect  to  IgM  immunoglobulin levels. 
Although all low responders had low IgM levels, both high and intermediate 1508  GENETIC  CONTROL  OF  ANTIBODY  RESPONSE  TO  SSS-III. II. 
responders had high IgM levels of the same magnitude  (Tables III and IV). 
Furthermore, CBA/CaJ mice had IgM levels, equal to those of high responding 
B mice; yet, these mice gave a low to intermediate antibody response to SSS- 
III  (Table VII). These findings indicate that  high  IgM  levels per se  do not 
necessarily  determine  whether  mice  will  give  a  high  antibody  response  to 
SSS-III. 
Despite the almost monoclonal characteristics of the antibody response to 
SSS-III,  the  genetic mechanisms  that  govern responsiveness to  this  antigen 
of relatively simple  structure appear  to  be  quite  complex. They include  an 
X-linked dominant gene that determines responsiveness to SSS-III in a decisive 
manner (1), in addition to other factors, presumably autosomal genes, that in- 
fluence the  magnitude  of  the  response produced by mice  possessing  the  X- 
linked gene (1, 29). The following observations, derived from these and other 
studies  (1,  Tables I  and  II),  best  illustrate  some of the  quantitative  effects 
which appear to be produced by the latter. 
First~  the  results  of previous studies  showed  that  for  B  mice  immunized 
with SSS-III there was a direct relationship between the magnitude of the PFC 
response and the serum hemolytic antibody titer obtained (10,  11).  However, 
among  groups of hybrids having identical  genotypes with  respect  to  the X- 
linked gene,  this  relationship did not  always exist. When  the  responses pro- 
duced by such  groups  of mice were  compared,  significant  differences in  the 
magnitude of the PFC response frequently were not accompanied by significant 
differences in the magnitude of the serum antibody response and conversely. 
Second,  high  and  intermediate  responding mice,  having  identical  genotypes 
with respect to the X-linked gene, may differ significantly in their ability to 
respond to SSS-III. This is most evident when one compares the  results ob- 
tained  with progeny derived from  (a)  backcrosses  to  C  or B  mice,  and  (b) 
backcrosses to BC or CB mice. In the first case, without exception, mice de- 
rived from backcrosses to C mice gave responses that were lower than those of 
mice derived from corresponding backcrosses to B mice. In the second case, for 
at least two of the three immunological parameters considered, mice derived 
from backcrosses to BC mice invariably gave lower responses than those pro- 
duced by mice derived from backcrosses to CB mice. The above observations 
apply regardless  of the genotype of the maternal or paternal member of the 
crosses considered. The results obtained with both types of F1 mice examined 
in  this  study  (Table II)  further serve to illustrate some of the  quantitative 
differences noted between groups of mice having identical genotypes and em- 
phasize the need for conducting reciprocal crosses in all studies on the genetic 
control of the immune response to avoid making erroneous conclusions. Third, 
among all X+Y mice examined, BC, BC/BC, B/BC, and, BC/C mice, as well 
as all female B/BC mice (X+X  +) should have been high responders. Instead, 
these mice gave an intermediate PFC response and their serum antibody re- 
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While  the mechanisms responsible  for producing  these  and all  of the  other 
quantitative  effects considered  above  remain  to  be  defined,  they  could  be 
attributed  to differences between C  and B  mice with respect  to  regulatory, 
rather than structural,  gene functions. In  this context, the existence of two 
functionally distinct types of thymus-derived cells (amplifier and suppressor T 
cells),  that act in either a positive or a negative manner to influence the magni- 
tude of the antibody response to SSS-III (24, 30-34), implies that these activi- 
ties may be under separate genetic control and could act independently to regu- 
late the number of antibody-forming cells obtained after immunization and the 
amount of antibody synthesized by such cells (1). 
Although immunoglobulin levels and  antibody responses  other  than  IgM 
have thus far not been investigated in great detail, the results of preliminary 
studies indicate that (a)  C and B mice do not have IgG and IgA levels which 
differ significantly, and that (b) both types of mice, hyperimmunized with ferri- 
tin, give good IgG antibody responses to this antigen (unpublished observa- 
tions). Nevertheless, C mice provide an excellent experimental model for the 
study of X-linked immunologic deficiencies.  While the genetic defect observed 
is less severe than that described in clinical situations (5-8),  the present work 
provides some indications concerning the level of the immune response at which 
such a defect can occur and clearly shows that C mice possess cells fully capable 
of synthesizing IgM  immunoglobulin in  large  quantity if  specific  antigenic 
stimulation is bypassed. Further studies are being conducted to obtain more pre- 
cise information on the nature of this genetic defect which appears to involve a 
critical step in the process by which lymphocytes are triggered to  differentiate 
in response to antigen. 
SUMMARY 
Serum IgM immunoglobulin levels and antibody responses to an optimally 
immunogenic dose of Type III pneumococcal polysaccharide (SSS-III)  were 
assessed for F1, F2, and backcross progeny derived from crosses between high 
responding BALB/cAnN (B) and low responding CBA/HN (C) mice. The re- 
sults obtained confirmed our original hypothesis, namely, that a  major com- 
ponent, present on the X chromosome, governs the ability to respond to SSS-III 
in a decisive manner. Although all low responding C mice had low IgM levels, 
both intermediate and high responders had high IgM levels of the same magni- 
tude. Treatment with bacterial lipopolysaccharides (LPS) resulted in a  signifi- 
cant increase in the IgM levels of low responding C mice. While the IgM levels 
attained were similar to those of high responding B mice, not given LPS, no 
antibody specific for LPS appeared to be produced. These findings suggest that 
C mice are unable to make an IgM antibody response to SSS-III and other 
polysaccharide antigens, despite the fact that they possess the capacity to syn- 
thesize normal amounts of IgM immunoglobulin. 1510  GENETIC  CONTROL OF  ANTIBODY RESPONSE TO  SSS-III.  II. 
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